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Edited by Sandro SonninoAbstract We investigated the localization and functional
expression of the ABC transporter ABCB1 in human fetal neural
stem/progenitor cells (hNSPCs). RT-PCR analysis revealed
ABCB1 gene expression in hNSPCs. We found a single band
in immunoblotted hNSPCs lysates probed with ABCB1 anti-
body, and detected ABCB1 at the hNSPCs cell membrane by
immunocytochemistry and subcellular fractionation. ABCB1
inhibitors and substrate, and ATP-depleting agents enhanced
hNSPCs rhodamine 123 accumulation, and hNSPCs micro-
somes had vanadate-sensitive ATPase activity. ABCB1 and nes-
tin expression decreased during hNSPCs diﬀerentiation, while
the astroglial marker GFAP increased. ABCB1 may maintain
hNSPCs in an undiﬀerentiated state and could be a neural
stem/progenitor marker.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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surface marker1. Introduction
ATP-binding cassette (ABC) genes play a role in multidrug
resistance (MDR), and at least six ABC gene products, includ-
ing ABCB1 (P-glycoprotein, P-gp), ABCC1 (MRP1), ABCC2
(MRP2, cMOAT), and ABCG2 (BCRP, MXR, ABCP) are
associated with anticancer drug transport. The ABCB1 gene
maps to chromosome 7q21.1 and is the best-characterized
ABC drug transporter. Formerly known as MDR1 or PGY1,
ABCB1 was the ﬁrst human ABC transporter gene to be cloned
and characterized, based on its ability to confer an MDR phe-Abbreviations: ABC transporter, ATP-binding cassette transporter;
MDR, multidrug resistance; P-gp, P-glycoprotein; hNSPCs, human
neural stem/progenitor cells; SP, side-population; Rh123, rhodamine
123
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doi:10.1016/j.febslet.2005.05.019notype to cancer cells that had developed resistance to chemo-
therapy drugs [1]. The gene product, ABCB1 (P-gp), is a
promiscuous transporter of hydrophobic substrates, including
several anticancer drugs [2]. ABCB1 is a 170-kDa protein that
is expressed in many healthy organs, and is thought to play an
important role in removing toxic metabolites from cells [3].
ABCB1 is also expressed in primitive stem cells, including
human CD34 stem cells [4] and c-kit+ cells [5], which can be
identiﬁed by their ability to transport ﬂuorescent dyes that
are ABCB1 substrates, such as rhodamine 123 (Rh123) [6–8]
and Hoechst 33342 [9–11]. One way to purify these stem cells
is based on Hoechst dye staining of bone marrow cells to iden-
tify a minor fraction of side-population (SP) cells; this popu-
lation shows a high repopulating activity and ABCG2
expression [12,13]. SP cells have been identiﬁed among other
stem cells, such as mesenchymal, liver, and pancreatic stem
cells, and this population disappears with verapamil treatment
[12,14], indicating that the SP phenotype might result from the
expression of ABCB1 or another ABC transporter in a primi-
tive subset of stem cells in mammals [14,15]. Moreover, in par-
allel with nestin, the expression of ABCG2 and ABCB1 is
higher in pancreatic SP cells than in non-SP cells [14].
As in hematopoietic systems, neural stem cells cultured as
neurospheres contain a cell subpopulation that is characterized
by the exportation of Hoechst ﬂuorescence and gives rise to
cells that are similar to freshly isolated, uncultured neural stem
cells [16]. We very recently reported the functional expression
of ABCG2, an ABC transporter, in human neural stem/pro-
genitor cells (hNSPCs) [17]; however, unlike with hematopoi-
etic, mesenchymal, and pancreatic stem cells, little or nothing
is known about the expression or function of other ABC trans-
porters, especially ABCB1, in neural stem cells. Because
hNSPCs have received great attention for both their roles in
normal neural development and their potential use in treating
various intractable neuronal diseases or injuries, it is important
to determine the expression patterns of ABCB1 and its func-
tion in neural stem cells, especially hNSPCs.
Here we analyzed the expression pattern of the ABCB1
gene and its protein, and the function of the ABCB1 protein,
in hNSPCs. Our results demonstrated that ABCB1 wasblished by Elsevier B.V. All rights reserved.
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lated during diﬀerentiation, indicating that ABCB1 might be
important in maintaining hNSPCs in an undiﬀerentiated
state. These ﬁndings provide basic information that should
be useful for clinical applications of hNSPCs and suggest that
ABCB1 may be a useful marker for hNSPCs.2. Materials and methods
2.1. Antibodies and chemicals
The anti-MDR1 (p170; mouse monoclonal, used as the anti-ABCB1
antibody throughout the manuscript) and anti-P-gp (C219; mouse
monoclonal) antibodies were purchased from NeoMarkers (Fremont,
CA) and Alexis Biochemicals (San Diego, CA), respectively. Anti-glial
ﬁbrillary acidic protein (GFAP; rabbit polyclonal) and anti-human
nestin (mouse monoclonal and rabbit polyclonal) antibodies were from
Sigma (St. Louis, MO) and Chemicon (Temecula, CA), respectively.
Rh123, cyclosporin A, vincristine, and vinblastine were obtained from
Wako (Osaka, Japan).
2.2. hNSPCs culture and diﬀerentiation
Approval to use human fetal neural tissues was obtained from the
ethical committees of both Osaka National Hospital and the National
Institute of Advanced Industrial Science and Technology. Tissue pro-
curement was in accordance with the Declaration of Helsinki, the eth-
ical guidelines of the European Network for Transplantation
(NECTA), and the Japan Society of Obstetrics and Gynecology. Hu-
man NSPCs were isolated from three human fetal forebrain tissues
of 7, 9, and 10 weeks gestational age (GW) and cultured as described
[17–19]. (The three lots of NSPCs are designated 7GW, 9GW, and
10GW in the text and ﬁgures.) To induce glial diﬀerentiation, neuro-
spheres cultured for 4 days were plated either on a poly-ornithine-
coated glass disk (PLO-disk) or in a coated T25 Primaria culture ﬂask
(Becton–Dickinson, Franklin Lakes, NJ) and cultured for 15 days in
DMEM-high glucose medium plus 10% fetal bovine serum (FBS).
The glia were then passaged 4 more times. The diﬀerentiated glia on
PLO-disks were used for immunocytochemistry and those in the T25
ﬂasks for immunoblotting.
2.3. Immunocytochemical analysis
Neurospheres were ﬁxed in phosphate-buﬀered saline (PBS) contain-
ing 4% paraformaldehyde for 20 min at room temperature, embedded
in OCT-compound (Sakura Finetechnical, Tokyo, Japan), and sec-
tioned at 12-lm on a cryotome [18]. Single cells dissociated from neur-
ospheres (1 h post-plating on a glass disk) and diﬀerentiated cells were
also ﬁxed as above. The ﬁxed neurosphere sections and single cells on
glass disks were washed in PBS and blocked with 10% goat serum for
1 h at room temperature; they were then incubated overnight with
p170 (1:200) and anti-nestin (polyclonal 1:1000) antibodies in PBS con-
taining 10% normal goat serum at 4 C, while the diﬀerentiated cells
(glia) were incubated with p170 (1:500, monoclonal) and anti-GFAP
(polyclonal 1:80) antibodies using the same procedure. After being
washed, the samples were incubated with secondary antibodies (Alexa
Fluor 568 goat anti-rabbit IgG and Alexa Fluor 488 goat anti-
mouse IgG, Molecular Probes Inc. OR) at room temperature for 1
hr. Nuclei were stained with TO-PRO-3 (Molecular Probes Inc.
OR). Fluorescent signals were detected with a confocal scanning laser
microscope (LSM510, Carl Zeiss). The phenotypes of single cells were
quantiﬁed by counting the immunolabeled cells in four randomly cho-
sen ﬁelds from each of three coverslips
2.4. Reverse transcription polymerase chain reaction (RT-PCR)
analysis
Total RNA was isolated from 18-day-cultured 7GW, 9GW, and 10
GW neurospheres using an RNeasy kit (Qiagen Inc., Valencia, CA),
following the manufacturers protocol. Single-stranded cDNA was
made using the Superscript First-Strand System (Invitrogen, Carlsbad,
CA). The cDNAs were ampliﬁed by polymerase chain reaction (PCR).
The PCR products were analyzed by agarose gel electrophoresis and
their identities were conﬁrmed by sequencing. The template concentra-
tions were normalized for GAPDH (25 cycles), while ABCB1 (MDR1)was ampliﬁed for 31 cycles. Primers were 5 0-GGCCTAATGCCGAA-
CACATT-30 and 5 0-CAGCGTCTGGCCCTTCTTC-3 0 for ABCB1
and 5 0-CAACGGATTTGGTCGTATT-3 0 and 5 0-ATCTCGCTC-
CTGGAAGAT-3 0 for GAPDH.
2.5. Microsome preparation
Microsomes from neurospheres and diﬀerentiated cells (glia) were
prepared as described previously [20]. Brieﬂy, cell pellets were homoge-
nized using a glass-Teﬂon homogenizer in TEMP buﬀer (50 mM Tris–
HCl, pH 7.0, containing 50 mM mannitol, 2 mM EGTA, 10 lg/ml
leupeptin, 2 lg/ml pepstatin A, 0.5 mM PMSF, and 2 mM b-mercap-
toethanol), and the undisrupted cells and nuclear debris were removed
by centrifugation at 500 · g for 10 min. The supernatant was then spun
for 60 min at 100000 · g, and the pellet was suspended in TEMP buﬀer
at a protein concentration of 2–3 mg/ml (microsomes), and used for
vanadate-sensitive ATPase activity assays (ABCB1-associated ATPase
activity) and immunoblotting. The plasma membrane (PM) and endo-
plasmic reticulum (ER) fractions were separated from the microsomes
by sucrose density gradient, as described [17]. All procedures were car-
ried out at 4 C, and the samples were stored at 80 C until use.
2.6. Immunoblotting
For immunoblots, 30 lgmicrosomal proteins were separated by stan-
dard SDS–PAGE, transferred to PVDF membranes, and probed with
p170 (1:500), C219 (1:500), anti-nestin (polyclonal, 1:1000), or anti-
GFAP (1:1000) primary antibodies as described in the Figure legends.
Secondary antibodies were either anti-mouse or anti-rabbit HRP-conju-
gated antibodies (Amersham, UK). The proteins were visualized with
enhanced chemiluminescence (ECL system, Amersham, UK).
2.7. Rh123 accumulation
To determine the time-course of Rh123 accumulation, 9GW
hNSPCs were incubated at 37 C from 0 to 120 min in the presence
of Rh123 (5 lg/ml). To determine the eﬀects of modulators, control
hNSPCs or hNSPCs treated with cyclosporin A (20 lM), vincristine
(20 lM), or vinblastine (20 lM) were incubated for 90 min in the pres-
ence of 5 lg/ml Rh123 [21]. To investigate the dose-dependent eﬀect of
cyclosporin A on Rh123 accumulation, hNSPCs were incubated with
diﬀerent concentrations of cyclosporin A (5, 10, 15, or 20 lM) or with-
out cyclosporin A (control) for 90 min in the presence of Rh123 (5 lg/
ml). The cells were then washed three times with ice-cold Hanks buﬀer
containing 20 lM verapamil. They were solubilized with 0.3 M NaOH
and neutralized with 0.3 M HCl. The ﬂuorescence intensity of Rh123
was measured at an excitation wavelength of 485 nm and an emission
wavelength of 535 nm, using a spectroﬂuorophotometer (Shimadzu,
Tokyo, Japan).
2.8. Na+/K+-ATPase and vanadate-sensitive ATPase (ABCB1-
associated) activity measurements
The membrane ATPase activity of 9GW hNSPC microsomes was
measured by the colorimetric detection of inorganic phosphate (Pi) lib-
eration as described [17,20] with minor modiﬁcations. The reaction
mixture contained 40 mM MOPS–Tris (pH 7.0), 50 mM KCl, 2 mM
DTT, 5 mM EGTA, 5 mM sodium azide, and 30 lg microsomes.
The reaction was started by adding 3 mM Mg-ATP, and after
30 min was stopped with 2 ml malachite green. The Na+/K+-ATPase
activity was calculated as the diﬀerence between the activity in the ab-
sence and presence of 1 mM ouabain, and the vanadate-sensitive ATP-
ase (ABCB1) activity was determined by performing the assays with
1 mM ouabain in the absence or presence of 100 lm sodium-ortho-
vanadate. To determine the eﬀect of ATP, verapamil, cyclosporin A,
and calcein-AM on the vanadate-sensitive ATPase activity, micro-
somes from hNSPCs were incubated with diﬀerent concentrations of
ATP and the above-mentioned drugs.3. Results
3.1. Expression of the ABCB1 gene and protein, and localization
of ABCB1 in cultured hNSPCs
We ﬁrst detected the ABCB1 gene in the 7GW, 9GW, and
10GW hNSPCs using RT-PCR analysis. Using a gene-speciﬁc
Fig. 2. Cellular and subcellular localization of ABCB1 in hNSPCs
(neurospheres) and single cells. Human neurospheres (9GW) (A) and
single cells dissociated from neurospheres (B) stained with an anti-
ABCB1 antibody (p170) (three-dimensional picture). The nuclear stain
was TO-PRO-3. (C) 9GW hNSPC microsomes were separated into
ER and PM fractions. ABCB1 was detected in the microsome, PM,
+
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hNSPC lots (Fig. 1A). Equal loading of the total RNA for
each sample was conﬁrmed by GAPDH ampliﬁcation. We
then examined the expression of the ABCB1 protein
(MDR1, P-gp) in hNSPCs microsomes using the p170 and
C219 mouse monoclonal antibodies, and its localization in
hNSPCs. In immunoblots, both antibodies recognized a single
band at around 170 kDa in microsomes from all three hNSPCs
lots (Fig. 1B). These three hNSPCs lots also expressed nestin,
the neural stem/progenitor marker, for which we found a sin-
gle band at 220 kDa by immunoblotting (Fig. 1B).
To examine the localization of ABCB1 in hNSPCs, we per-
formed both immunocytochemical and biochemical analyses.
Immunocytochemical staining of neurosphere sections with
the p170 antibody labelled a large number of cells in the neur-
osphere (Fig. 2A). Three-dimensional analysis of whole single
cells dissociated from the neurospheres showed that the p170
antibody speciﬁcally stained the membrane of the hNSPCs
(Fig. 2B). Moreover, we found that ABCB1 was highly ex-
pressed in the PM fraction compared with the ER fraction,
and there was higher Na+/K+-ATPase activity in the PM frac-
tion, conﬁrming the separation of the PM preparation from
the microsomal fraction (Fig. 2C). These ﬁndings indicated
that in-vitro-cultured hNSPCs expressed the ABCB1 protein
in their PM.
3.2. Functional studies of the ABCB1 expressed in hNSPCs
To investigate the functional activity of the ABCB1 ex-
pressed in hNSPCs, we measured (1) the accumulation of
Rh123, an established ABCB1 substrate and (2) vanadate-
sensitive ATPase activity using the calcium-channel blocker
verapamil and the immunosuppressive peptide cyclosporin A,Fig. 1. Expression of the ABCB1 gene and ABCB1 protein in
hNSPCs. (A) RT-PCR analysis of the ABCB1 gene in 7GW, 9GW,
and 10GW hNSPCs. An ethidium bromide-stained gel showing the
ampliﬁcation of a speciﬁc band (approximately 125 bp) for ABCB1
from all three diﬀerent hNSPCs lots. GAPDH was used as a positive
control for total RNA. (B) Immunoblot detection of ABCB1 (MDR1
and P-glycoprotein) and nestin in hNSPC-derived microsomes.
Microsomal proteins (30 lg/lane) from three diﬀerent hNSPC lots
(7GW, 9GW, and 10GW) were separated by SDS–PAGE and probed
with p170, C219, and nestin (polyclonal) antibodies.
and ER fractions using the p170 antibody (upper panel), and the Na /
K+-ATPase activity of the three fractions is also shown (lower panel).
Values represent the means ± SD of three independent experiments
performed in duplicate.known as chemosensitizers, i.e., compounds that interfere with
ABCB1 transporters [21], and the vinka alkaloid, vinblastine,
an anticancer drug transported by ABCB1, that competes with
other substrates [22]. First, we studied the time course of
Rh123 accumulation in 9GW hNSPCs. In the presence of
5.5 lg/ml Rh123, the accumulation was linear for 90 min at
37 C, and then plateaued (Fig. 3A). Verapamil and cyclo-
sporin A, two well known ABCB1 inhibitors, and vinblastine,
an ABCB1 substrate, are reported to signiﬁcantly enhance
Rh123 accumulation in the HK-2 proximal tubular cell line
[23]. We found that Rh123 accumulation signiﬁcantly in-
creased when verapamil (20 lM), cyclosporin A (20 lM), or
vinblastine (20 lM) was added to the hNSPCs, compared with
the addition of Rh123 alone (Fig. 3B). Rh123 accumulation
also increased signiﬁcantly with increasing concentrations of
cyclosporin A (Fig. 3C). Thus, all these drugs signiﬁcantly en-
hanced the ABCB1-mediated Rh123 accumulation, indicating
the presence of an ABCB1-mediated eﬄux mechanism in
hNSPCs.
Drug-stimulated, vanadate-sensitive membrane ATPase
activity has been shown to be positively correlated with
ABCB1 gene expression [20]. We found an ATP-dependent
and vanadate-sensitive ATPase activity in hNSPC micro-
somes, measured by Pi liberation (Fig. 4A), which accounted
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Fig. 3. Accumulation of Rh123 by hNSPCs and the eﬀects of ABCB1 inhibitors and substrate on this accumulation. (A) Time course of Rh123
accumulation by 9GW hNSPCs. (B) Eﬀects of cyclosporin A (20 lM), verapamil (20 lM), and vinblastine (20 lM) on Rh123 accumulation. (C)
Dose-dependent eﬀect of cyclosporin A on Rh123 accumulation as discussed in the text. Values represent the means ± SD of three independent











































































Fig. 4. Eﬀect of ATP, ABCB1 inhibitors, and substrate on vanadate-sensitive ATPase activity. (A) ATP-dependent vanadate-sensitive ATPase
activity of 9GW hNSPC microsomes. (B) Eﬀect of verapamil, cyclosporin A, and calcein-AM on the vanadate-sensitive ATPase activity of hNSPC
microsomes as described in the text. Values represent the means ± SD of three independent experiments performed in duplicate.
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and of an ABCB1 substrate on the vanadate-sensitive ATPase
activity in hNSPC microsomes. Verapamil and cyclosporin A,
which compete for azidopine binding in ABCB1-expressing Sf9
membranes [20], and calcein-AM, a ﬂuorescent substrate used
to measure ABCB1-mediated transport activity [24], activated
the membrane ATPase in the 1–100 lM concentration range,
consistent with the eﬀect of these drugs on the reversal of drugresistance and ABCB1 function in intact cells [20]. Very re-
cently, Ejendal and Hrycyna [25] reported that human ABCG2
and ABCB1, despite having overlapping substrate speciﬁcities,
diﬀer in their sensitivity to the immunomodulator cyclosporin
A, and that cyclosporin A is neither a substrate nor an inhib-
itor of the human ABCG2 transporter. Moreover, cyclosporin
A has no eﬀect on the basal and prazosin-stimulated ATPase
activity of ABCG2. Therefore, the cyclosporin A-induced
M.O. Islam et al. / FEBS Letters 579 (2005) 3473–3480 3477increase in Rh123 accumulation, and the vanadate-sensitive
ATPase activity indicate the functional presence of ABCB1
in hNSPCs.
3.3. Phenotype analysis of the ABCB1-positive cells in human
hNSPCs
Because hNSPCs (neurosphere) are heterogeneous cell mix-
ture [17,18], we compared the population of ABCB1-positive
cells in hNSPCs to that of nestin-positive cells, because nestin
is a neural stem/progenitor cell marker [17,18]. We dissociated
neurospheres into single cells, stained the cells with anti-
ABCB1 (p170) and anti-nestin antibodies, and counted the
ABCB1-positive, nestin-positive, and ABCB1/nestin double-
positive cells. There were slightly more ABCB1-positive cells
in the neurospheres than nestin-positive cells, but most of
the nestin-positive cells were also ABCB1-positive (Fig. 5);
therefore, most of the ABCB1-positive cells present in neuro-
spheres were nestin-positive stem or progenitor cells.
3.4. Downregulation of ABCB1 expression during hNSPCs
diﬀerentiation
To investigate whether the expression of ABCB1 was related
to the maintenance of the progenitor state of hNSPCs, we in-
duced hNSPCs to diﬀerentiate into GFAP-positive human glia
[17] and compared the expression of ABCB1, nestin (neural
stem/progenitor marker), and GFAP (astroglia marker) in
hNSPCs with their expression in the diﬀerentiated glia by
immunoblotting. ABCB1 (p170) expression was downregu-
lated in parallel with nestin expression, as the hNSPCs diﬀer-
entiated, and their expression was further decreased with the
passage number of the glial cultures, whereas the astroglial
marker GFAP was upregulated with the passage numberFig. 5. Phenotype analysis of the ABCB1- and nestin-positive cells in hNSPC
and double-immunostained with anti-ABCB1 (p170) and anti-nestin (polyc
positive cells, and of ABCB1/nestin double-positive cells were counted. The(Fig. 6A). The vanadate-sensitive ATPase activity was also
greater in the hNSPCs than in the glia, indicating that ABCB1
activity was higher in stem/progenitor cells than in diﬀerenti-
ated cells (Fig. 6B).
To determine the expression pattern of ABCB1 in the diﬀer-
entiated glia, we double-immunostained the glia with the p170
and anti-GFAP antibodies, and found that most of the diﬀer-
entiated glia were GFAP-positive but ABCB1-negative, and
only a few glia were doubly positive for ABCB1 and GFAP
(Fig. 6C). Thus, the glia expressed a very low level of ABCB1
(p170) compared with the stem/progenitor cells, indicating that
ABCB1 was mainly expressed by cells in the undiﬀerentiated
state.4. Discussion
Recent studies have demonstrated the expression of ABCB1
in cultured hematopoietic, mesenchymal, and pancreatic stem
cells, especially in the SP cells, deﬁned by ABCB1-mediated
Rh123 eﬄux [12–15]. Hulspas and Quesenberry [16] speculated
that the SP phenotype of cultured rat neural stem cells might
be due to ABCB1-mediated Rh123 eﬄux; however, they did
not demonstrate ABCB1 expression in these cells. Moreover,
although functional ABCB1 gene expression in primitive hu-
man hematopoietic and pancreatic stem cells is well described
[4,14], little or nothing was known about its expression in neu-
ral stem cells, especially hNSPCs. Here, we showed for the ﬁrst
time that cultured hNSPCs expressed functional ABCB1 in
their cell membrane that was downregulated during hNSPCs
diﬀerentiation, and that ABCB1 could be used as a stem/pro-
genitor marker in hNSPCs. Its presence in the PM suggesteds (neurospheres). Human neurospheres were dissociated into single cells
lonal) antibodies. The individual populations of ABCB1- and nestin-
nuclear stain was TO-PRO-3 (scale bar = 20 lm).
Fig. 6. Expression of ABCB1, nestin, and GFAP during hNSPCs diﬀerentiation into glia. (A) Human 9GW NSPCs (neurospheres) were induced to
diﬀerentiate into glia and then passaged four times (lanes 1–4). The immunoblot showed the time course expression of ABCB1 (p170), nestin, and
GFAP during the diﬀerentiation from hNSPCs. (B) The vanadate-sensitive ATPase activity of microsomes from hNSPCs and diﬀerentiated glia (at
the 4th passage). Values represent the means ± SD of three independent experiments performed in duplicate. (C) Expression pattern of ABCB1 and
GFAP-positive cells in diﬀerentiated glia with p170 and anti-GFAP antibodies (scale bar = 20 lm).
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other toxic materials [26,27].
Assays based on the observation of ﬂuorescent dye accumu-
lation have been used to diagnose ABCB1-dependent drug
resistance in clinical tumor samples or to study the function
of ABCB1 in cells from normal tissues, including isolated
hepatocytes [28,29]. We used this type of assay and examined
the accumulation of Rh123 in hNSPCs treated with com-
pounds that interfere with ABCB1 transport and are them-
selves ABCB1 substrates [21]. The mechanisms for ABCB1
modulation may be diﬀerent for diﬀerent classes of com-
pounds. Two types of interaction exist. First, some compounds
interact directly with one or more of the binding sites on
ABCB1, blocking the transport of substrates (e.g., verapamil,
cyclosporin A) as competitive or non-competitive inhibitors.
Second, some inhibit ATP binding (e.g., vanadate), ATP
hydrolysis, or the coupling of ATP hydrolysis to the transloca-
tion of the substrate [2]. These compounds increased the
Rh123 accumulation in hNSPCs, indicating that they inhibited
and/or interfered with the ABCB1 activity. In addition to
Rh123 accumulation, we studied the vanadate-sensitive ATP-
ase activity in hNSPCs. As with the other agents, the cal-
cium-channel blocker verapamil and the immunosuppressive
peptide cyclosporin A stimulated the ATP hydrolysis activity
over baseline in a concentration-dependent manner. Together,
these ﬁndings indicated that ABCB1 is functionally expressed
at the cell surface of hNSPCs.
Having shown the functional expression of ABCB1 in
hNSPCs, an important next step was to determine whether
its expression is related to the cellular phenotype of stem/pro-
genitor cells. Neurospheres formed of hNSPCs are heteroge-
neous, and we found that about 50–70% of the hNSPCs
within neurospheres expressed nestin (a neural stem/progenitor
marker) [17]. Futhermore, we showed that all the nestin-posi-
tive cells also expressed ABCB1. Therefore, ABCB1 might beuseful as a new marker of neural stem/progenitor cells. Lech-
ner et al. [14] showed that there were high levels of ABCB1,
ABCG2, and nestin expression in pancreatic SP cells compared
with non-SP cells and that SP cells were totally lost upon
verapamil treatment. Using an ABCG2 knockout mouse,
Zhou et al. [26] showed that ABCG2 was responsible for the
SP phenotype and was sharply downregulated with hemato-
poietic maturation; they suggested that ABCG2 might protect
the stem cells from genetic damage, and therefore the ABC
transporter expression in stem cells might reﬂect a required
function. In addition, Bunting et al. [15] reported that the
forced ABCB1 pump function in bone marrow cells results
in the expansion of SP stem cells in vitro and the repopulation
of these cells in vivo, demonstrating a functional link between
stem-cell phenotype and ABCB1 expression. We also found
that cyclosporin A inhibited hNSPCs proliferation with very
low doses (Islam et al. in preparation). Furthermore, we
showed a correlation between nestin and ABCB1 expression
in hNSPCs (Fig. 1). Taking these ﬁndings together, we propose
that the ABC transporter may contribute to neural stem/pro-
genitor cell expansion in vitro.
The most important ﬁnding of the present investigation was
the downregulation of ABCB1 during hNSPC diﬀerentiation.
The expression of ABCB1 and nestin was downregulated as
the hNSPCs diﬀerentiated, whereas GFAP was upregulated.
As the upregulation of GFAP and downregulation of nestin
are considered to be indicators of stem/progenitor diﬀerentia-
tion and/or maturation [30,31], our present and previous ﬁnd-
ings [17] that both ABC transporters (ABCB1 and ABCG2)
are downregulated establish their speciﬁc expression in
hNSPCs; it follows that ABCB1 and ABCG2 could be consid-
ered new neural stem/progenitor markers. Our present ﬁndings
that ABCB1 and nestin are downregulated during diﬀerentia-
tion are similar to those of Huang and Tang [32], who showed
that during the diﬀerentiation of nestin-positive islet-derived
M.O. Islam et al. / FEBS Letters 579 (2005) 3473–3480 3479progenitor cells, the ABCG2 and nestin expression fell.
Although one previous report [33] showed the expression of
ABCB1 in cultured rat astrocytes, the reported expression level
was very low, and no co-localization of ABCB1 and GFAP in
the astrocytes was seen [34]. Thus, the published data and our
results indicate that diﬀerentiated glia express a very low level
of ABCB1 compared with stem/progenitor cells. All these ﬁnd-
ings together suggest that ABC transporters, at least ABCB1
and/or ABCG2, could be a selective marker of neural stem/
progenitor cells, distinguishing them from diﬀerentiated/ma-
ture cells.
The overexpression of ABCB1 in bone marrow cells leads to
the expansion of the SP, its prolonged survival in culture, and
its enhanced repopulation after transplantation into mice [15].
Therefore, ABCB1 expression is likely to be a characteristic of
proliferating stem cells and not of quiescent cells. Very re-
cently, Israeli et al. [35] suggested that the biological activities
of ABCB1 and ABCG2 in stem cells are part of the normal tis-
sue regeneration mechanism, and are probably involved in
protecting the small stem-cell population from cell death and
preserving stem-cell homeostasis under extreme stress condi-
tions. At present, the normal physiological function and signif-
icance of ABC transporter expression in hNSPCs is not clear,
but it may help to protect hNSPCs from xenobiotics and other
toxic substances or to maintain proliferating stem cells in an
undiﬀerentiated state [26]. The present ﬁndings and our previ-
ous observations of ABCG2 transporter expression in hNSPCs
strongly suggest a functional link between the progenitor phe-
notype and ABC transporter expression. In addition, as
ABCB1 or ABCG2 is expressed on the cell surface of hNSPCs,
antibodies against these transporters could be used for isolat-
ing stem/progenitor cells from neurospheres using ﬂow cytom-
etry. We are presently investigating this possibility.
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